About Prostate Cancer Treatment
Prostate cancer is managed by a urologic oncologist with a radiation oncologist and, in advanced disease, a medical oncologist. It is one of the few cancers where close monitoring without immediate treatment is a legitimate option in selected low-risk cases.
This guide explains what the hospital assesses and what to ask. It is background reading, not medical advice.
Risk group, not just stage
Decisions rest on the combination of PSA level, the Gleason score or grade group from the biopsy, and the clinical stage. Together these place the cancer in a risk group, and the risk group, more than any single number, drives what is recommended.
Because some prostate cancers grow very slowly, treating every case aggressively is not automatically better. Active surveillance, structured monitoring with repeat PSA, imaging and biopsy, may be offered for low-risk disease. If it is suggested to you, ask what the monitoring schedule would be and whether it can be run by a urologist at home.
What the hospital needs before it can plan
The biopsy report with Gleason score or grade group, PSA history rather than a single reading, a multiparametric MRI of the prostate on disc, a bone scan or PSMA PET-CT where available, and records of any treatment already given.
Treatment approaches
Radical prostatectomy
The prostate is removed, increasingly using a robotic approach at the larger partner hospitals. Nerve-sparing technique may be possible depending on tumour position.
Radiation therapy
External beam radiation over several weeks, or brachytherapy with seeds placed in the prostate. Often combined with hormone therapy in intermediate and high-risk disease.
Hormone and systemic therapy
Androgen deprivation therapy reduces testosterone, which most prostate cancers depend on. In advanced disease this is combined with other drugs. It is usually continued for months or years and is often managed at home after the initial phase.
Side effects deserve a straight answer
Urinary control and sexual function can be affected by both surgery and radiation, to different degrees and on different timelines. These are routine clinical questions and the hospital should answer them specifically for your case, not in general terms. Ask what rehabilitation is offered.
Questions worth asking the treating hospital
What is my risk group, and is surveillance reasonable? If treatment is advised, what are the trade-offs between surgery and radiation for me? Is nerve-sparing possible? What is the realistic expectation for urinary and sexual function, and over what timeline? How much of the hormone therapy can be given at home?
Ask the hospital for its own case volumes and outcomes, including continence and potency figures if it publishes them.
How Massvaa Care helps
We share your reports with the oncology teams at partner hospitals, return their written plan and itemised estimate on hospital letterhead, and coordinate the visa invitation, arrival and accommodation. We do not give medical opinions and we do not take a share of your treatment cost. You pay the hospital directly.
Any range quoted before the tumour board has reviewed your case is indicative only. Cancer costs vary widely with stage, subtype and the number of cycles, so the hospital's written estimate is the figure to rely on.
